chr11-558030-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_173573.3(LMNTD2):c.409C>T(p.His137Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000095 in 1,579,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173573.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LMNTD2 | ENST00000329451.8 | c.409C>T | p.His137Tyr | missense_variant | Exon 5 of 14 | 1 | NM_173573.3 | ENSP00000331167.3 | ||
| LMNTD2 | ENST00000441853.5 | c.430C>T | p.His144Tyr | missense_variant | Exon 6 of 9 | 3 | ENSP00000393529.1 | |||
| LMNTD2 | ENST00000486629.1 | c.439C>T | p.His147Tyr | missense_variant | Exon 5 of 7 | 5 | ENSP00000435529.1 | |||
| LMNTD2-AS1 | ENST00000527620.5 | n.436G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152224Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000134 AC: 3AN: 223630 AF XY: 0.0000166 show subpopulations
GnomAD4 exome AF: 0.00000420 AC: 6AN: 1426930Hom.: 0 Cov.: 37 AF XY: 0.00000425 AC XY: 3AN XY: 705728 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74366 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.409C>T (p.H137Y) alteration is located in exon 5 (coding exon 5) of the LMNTD2 gene. This alteration results from a C to T substitution at nucleotide position 409, causing the histidine (H) at amino acid position 137 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at